BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 28178620)

  • 21. STAT1-induced upregulation of lncRNA LINC01123 predicts poor prognosis and promotes the progression of endometrial cancer through miR-516b/KIF4A.
    Yang Y; Wu J; Zhou H; Liu W; Wang J; Zhang Q
    Cell Cycle; 2020 Jun; 19(12):1502-1516. PubMed ID: 32401659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CircRNA WHSC1 targets the miR-646/NPM1 pathway to promote the development of endometrial cancer.
    Liu Y; Chen S; Zong ZH; Guan X; Zhao Y
    J Cell Mol Med; 2020 Jun; 24(12):6898-6907. PubMed ID: 32378344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osthole inhibited cell proliferation and induced cell apoptosis through decreasing CPEB2 expression via up-regulating miR-424 in endometrial carcinoma.
    Lu K; Lin J; Jiang J
    J Recept Signal Transduct Res; 2020 Feb; 40(1):89-96. PubMed ID: 31971049
    [No Abstract]   [Full Text] [Related]  

  • 24. Long noncoding RNA CHL1-AS1 promotes cell proliferation and migration by sponging miR-6076 to regulate CHL1 expression in endometrial cancer.
    Shi Y; Zha J; Zuo M; Yan Q; Song H
    J Cell Biochem; 2020 Mar; 121(3):2655-2663. PubMed ID: 31736153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of metastasis-associated in colon cancer 1 (MACC1) in endometrial carcinoma tumorigenesis and progression.
    Chen S; Zong ZH; Wu DD; Sun KX; Liu BL; Zhao Y
    Mol Carcinog; 2017 Apr; 56(4):1361-1371. PubMed ID: 27991682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression.
    Dong P; Ihira K; Xiong Y; Watari H; Hanley SJ; Yamada T; Hosaka M; Kudo M; Yue J; Sakuragi N
    Oncotarget; 2016 Apr; 7(15):20260-70. PubMed ID: 26934121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LINC01410/miR-23c/CHD7 functions as a ceRNA network to affect the prognosis of patients with endometrial cancer and strengthen the malignant properties of endometrial cancer cells.
    Lu M; Ding N; Zhuang S; Li Y
    Mol Cell Biochem; 2020 Jun; 469(1-2):9-19. PubMed ID: 32314193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma].
    Zhang G; Li XP; Wang JL; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):839-45. PubMed ID: 23302125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4.
    Zhao Y; Li F; Zhang X; Liu A; Qi J; Cui H; Zhao P
    Int J Clin Exp Pathol; 2015; 8(10):12446-54. PubMed ID: 26722431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promoter Methylation-mediated Silencing of the MiR-192-5p Promotes Endometrial Cancer Progression by Targeting ALX1.
    Ni J; Tian W; Liang S; Wang H; Ren Y
    Int J Med Sci; 2021; 18(12):2510-2520. PubMed ID: 34104082
    [No Abstract]   [Full Text] [Related]  

  • 31. Circ_0109046 promotes the malignancy of endometrial carcinoma cells through the microRNA-105/SOX9/Wnt/β-catenin axis.
    Li Y; Liu J; Piao J; Ou J; Zhu X
    IUBMB Life; 2021 Jan; 73(1):159-176. PubMed ID: 33220169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metastasis-associated protein 1, modulated by miR-30c, promotes endometrial cancer progression through AKT/mTOR/4E-BP1 pathway.
    Xu X; Kong X; Liu T; Zhou L; Wu J; Fu J; Wang Y; Zhu M; Yao S; Ding Y; Ding L; Li R; Zhu X; Tang X; Zhang Y; Yang Q; Ling J; Zhou H
    Gynecol Oncol; 2019 Jul; 154(1):207-217. PubMed ID: 30979588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-544a Stimulates endometrial carcinoma growth via targeted inhibition of reversion-inducing cysteine-rich protein with Kazal motifs.
    Zheng WP; Meng FL; Wang LY
    Mol Cell Probes; 2020 Oct; 53():101572. PubMed ID: 32525042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
    Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
    PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-424 may function as a tumor suppressor in endometrial carcinoma cells by targeting E2F7.
    Li Q; Qiu XM; Li QH; Wang XY; Li L; Xu M; Dong M; Xiao YB
    Oncol Rep; 2015 May; 33(5):2354-60. PubMed ID: 25708247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-191 regulates endometrial cancer cell growth via TET1-mediated epigenetic modulation of APC.
    Yang C; Ota-Kurogi N; Ikeda K; Okumura T; Horie-Inoue K; Takeda S; Inoue S
    J Biochem; 2020 Jul; 168(1):7-14. PubMed ID: 32003827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploration of miR-1202 and miR-196a in human endometrial cancer based on high throughout gene screening analysis.
    Chen H; Fan Y; Xu W; Chen J; Meng Y; Fang D; Wang J
    Oncol Rep; 2017 Jun; 37(6):3493-3501. PubMed ID: 28440476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-214/199a/199a* cluster levels predict poor survival in hepatocellular carcinoma through interference with cell-cycle regulators.
    Wang P; Chen S; Fang H; Wu X; Chen D; Peng L; Gao Z; Xie C
    Oncotarget; 2016 Jan; 7(1):929-45. PubMed ID: 26498144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo.
    Jiang F; Liu T; He Y; Yan Q; Chen X; Wang H; Wan X
    BMC Cancer; 2011 Oct; 11():425. PubMed ID: 21970405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.